We revealed that the expression and activity of MMP-12 is augmented within atherosclerotic AAAs and demonstrated that inhibition of MMP-12 activity protects from both atherosclerotic AAA formation and progression through dampening of macrophage accumulation and associated elastin degradation. The gene discussed is ELN; the disease is triple-A syndrome.